119 related articles for article (PubMed ID: 21768699)
1. Osteopontin expression in nasopharyngeal carcinoma: its relevance to the clinical stage of the disease.
Wang HH; Wang XW; Tang CE
J Cancer Res Ther; 2011; 7(2):138-42. PubMed ID: 21768699
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of osteopontin promotes cell proliferation and migration in human nasopharyngeal carcinoma and is associated with poor prognosis.
Qin H; Wang R; Wei G; Wang H; Pan G; Hu R; Wei Y; Tang R; Wang J
Eur Arch Otorhinolaryngol; 2018 Feb; 275(2):525-534. PubMed ID: 29214433
[TBL] [Abstract][Full Text] [Related]
3. Osteopontin promotes EZH2 expression and tumor progression in nasopharyngeal carcinoma.
Ma R; Luo X; Feng S; Li J; Fan Y; Wen W; Li H
ORL J Otorhinolaryngol Relat Spec; 2014; 76(5):273-81. PubMed ID: 25471249
[TBL] [Abstract][Full Text] [Related]
4. Osteopontin is a useful predictor of bone metastasis and survival in patients with locally advanced nasopharyngeal carcinoma.
Hou X; Wu X; Huang P; Zhan J; Zhou T; Ma Y; Qin T; Luo R; Feng Y; Xu Y; Chen L; Zhang L
Int J Cancer; 2015 Oct; 137(7):1672-8. PubMed ID: 25824984
[TBL] [Abstract][Full Text] [Related]
5. Osteopontin regulates growth and migration of human nasopharyngeal cancer cells.
Yang G; Zhang Y; Wu J; Xiong J; Deng H; Wang J; Yang C; Zhu Z
Mol Med Rep; 2011; 4(6):1169-73. PubMed ID: 21785824
[TBL] [Abstract][Full Text] [Related]
6. FLJ10540 is associated with tumor progression in nasopharyngeal carcinomas and contributes to nasopharyngeal cell proliferation, and metastasis via osteopontin/CD44 pathway.
Chen CH; Shiu LY; Su LJ; Huang CY; Huang SC; Huang CC; Yin YF; Wang WS; Tsai HT; Fang FM; Chuang WC; Kang HC; Hwang CF
J Transl Med; 2012 May; 10():93. PubMed ID: 22591637
[TBL] [Abstract][Full Text] [Related]
7. Elevation of plasma osteopontin level in patients with undifferentiated nasopharyngeal carcinoma.
Wong TS; Kwong DL; Sham J; Wei WI; Kwong YL; Yuen AP
Eur J Surg Oncol; 2005 Jun; 31(5):555-8. PubMed ID: 15922893
[TBL] [Abstract][Full Text] [Related]
8. Matrix Metalloproteinase 14 Overexpression Is Correlated with the Progression and Poor Prognosis of Nasopharyngeal Carcinoma.
Yan TH; Lin ZH; Jiang JH; Lu SW; Que HX; Chen MA; He XS; Que GB; Xiao JN; Chen YQ
Arch Med Res; 2015 Apr; 46(3):186-92. PubMed ID: 25829357
[TBL] [Abstract][Full Text] [Related]
9. CDK3 expression and its clinical significance in human nasopharyngeal carcinoma.
Wang L; Hu HY; Lin YL; Zhao ZX; Tan L; Yu P; Wan HJ; Jin Z; Zheng D
Mol Med Rep; 2014 Jun; 9(6):2582-6. PubMed ID: 24691537
[TBL] [Abstract][Full Text] [Related]
10. Association of osteopontin polymorphisms with nasopharyngeal carcinoma risk.
Wang J; Nong L; Wei Y; Qin S; Zhou Y; Tang Y
Hum Immunol; 2014 Jan; 75(1):76-80. PubMed ID: 24120738
[TBL] [Abstract][Full Text] [Related]
11. JMJD2A promotes the Warburg effect and nasopharyngeal carcinoma progression by transactivating LDHA expression.
Su Y; Yu QH; Wang XY; Yu LP; Wang ZF; Cao YC; Li JD
BMC Cancer; 2017 Jul; 17(1):477. PubMed ID: 28693517
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of osteopontin expression in human gastric carcinoma.
Higashiyama M; Ito T; Tanaka E; Shimada Y
Ann Surg Oncol; 2007 Dec; 14(12):3419-27. PubMed ID: 17896150
[TBL] [Abstract][Full Text] [Related]
13. Expression level of NUAK1 in human nasopharyngeal carcinoma and its prognostic significance.
Liu J; Tang G; Huang H; Li H; Zhang P; Xu L
Eur Arch Otorhinolaryngol; 2018 Oct; 275(10):2563-2573. PubMed ID: 30121842
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of integrin αv in the human nasopharyngeal carcinoma associated with metastasis and progression.
Xuan SH; Zhou YG; Pan JQ; Zhu W; Xu P
Cancer Biomark; 2013; 13(5):323-8. PubMed ID: 24440971
[TBL] [Abstract][Full Text] [Related]
15. Prostate Tumor Overexpressed 1 (PTOV1) Is a Novel Prognostic Marker for Nasopharyngeal Carcinoma Progression and Poor Survival Outcomes.
Yang Q; Lin H; Wu S; Lei F; Zhu X; Song L; Hong M; Guo L
PLoS One; 2015; 10(8):e0136448. PubMed ID: 26305455
[TBL] [Abstract][Full Text] [Related]
16. [Expression and clinical significance of cyclin E2 in nasopharyngeal carcinoma].
Zhao GH; Xie GQ; Miao YY
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Mar; 28(3):291-3. PubMed ID: 22394640
[TBL] [Abstract][Full Text] [Related]
17. Loss of cytoplasmic KLF4 expression is correlated with the progression and poor prognosis of nasopharyngeal carcinoma.
Liu Z; Yang H; Luo W; Jiang Q; Mai C; Chen Y; Zhen Y; Yu X; Long X; Fang W
Histopathology; 2013 Sep; 63(3):362-70. PubMed ID: 23758499
[TBL] [Abstract][Full Text] [Related]
18. [Inactivation of PMS2 gene by promoter methylation in nasopharyngeal carcinoma].
Ni HF; Jiang B; Zhou Z; Li Y; Yuan XY; Cao XL; Huang GW
Zhonghua Zhong Liu Za Zhi; 2016 Nov; 38(11):812-817. PubMed ID: 27998438
[No Abstract] [Full Text] [Related]
19. Correlation between OPN gene polymorphisms and the risk of nasopharyngeal carcinoma.
Wang JL; Nong LG; Tang YJ; Wei YS; Yang FL; Wang CF
Med Oncol; 2014 Jul; 31(7):20. PubMed ID: 24913806
[TBL] [Abstract][Full Text] [Related]
20. High expression of Zinc-finger protein X-linked is associated with reduced E-cadherin expression and unfavorable prognosis in nasopharyngeal carcinoma.
Li Y; Yan X; Yan L; Shan Z; Liu S; Chen X; Zou J; Zhang W; Jin Z
Int J Clin Exp Pathol; 2015; 8(4):3919-27. PubMed ID: 26097576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
